Edition:
United Kingdom

RTI Surgical Inc (RTIX.OQ)

RTIX.OQ on NASDAQ Stock Exchange Global Select Market

4.65USD
16 Feb 2018
Change (% chg)

$0.05 (+1.09%)
Prev Close
$4.60
Open
$4.55
Day's High
$4.65
Day's Low
$4.45
Volume
29,620
Avg. Vol
31,937
52-wk High
$6.00
52-wk Low
$3.03

Latest Key Developments (Source: Significant Developments)

RTI Surgical Outlines 2018 Guidance And Long-Term Goals
Friday, 5 Jan 2018 

Jan 5 (Reuters) - RTI Surgical Inc ::RTI SURGICAL OUTLINES 2018 GUIDANCE AND LONG-TERM GOALS.RTI SURGICAL INC - EXPECTS FULL YEAR REVENUES IN RANGE OF $280 MILLION AND $290 MILLION.RTI SURGICAL INC - ‍EXPECTS FULL YEAR EBITDA TO BE IN RANGE OF $32 MILLION TO $38 MILLION​.RTI SURGICAL - CO TO EXPAND REVENUE TO MORE THAN $500 MILLION​ AS ‍LONG-TERM FINANCIAL GOAL, EXPECTED TO BE ACHIEVED WITHIN FIVE YEARS.RTI SURGICAL - CO TO ‍DOUBLE EBITDA MARGIN TO MORE THAN 20 PERCENT AS LONG TERM FINANCIAL GOAL, EXPECTED TO BE ACHIEVED WITHIN FIVE YEARS ​.  Full Article

RTI Surgical Announces Acquisition Of Zyga Technology
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - RTI Surgical Inc ::RTI SURGICAL ANNOUNCES ACQUISITION OF ZYGA TECHNOLOGY, INC..RTI SURGICAL INC - TERMS OF DEAL WERE NOT DISCLOSED..RTI SURGICAL - CO TO FUND DEAL WITH CASH AND BORROWING UNDER EXISTING CREDIT FACILITY.  Full Article

RTI Surgical receives warning letter from FDA
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - RTI Surgical Inc :On Nov 9, co received a warning letter from FDA resulting from an inspection of co's facility in Alachua, Florida in April.Warning letter relates to processes used in manufacture of map3 cellular allogeneic bone graft product ​.Warning letter also relates to FDA's views with respect to map3 allograft's regulatory classification​.Warning letter does not restrict production, marketing, or distribution of map3 allograft​.Intends to conduct clinical studies that further confirm safety and efficacy of map3(reg) allograft​.  Full Article

RTI Surgical Q3 earnings per share $0.23
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - RTI Surgical Inc ::RTI Surgical announces 2017 third quarter results.Q3 earnings per share $0.23.Q3 earnings per share view $0.01 -- Thomson Reuters I/B/E/S.Sees FY 2017 adjusted earnings per share $0.05 to $0.07.Sees FY 2017 earnings per share $0.21 to $0.23.Q3 adjusted earnings per share $0.01 excluding items.Sees FY 2017 revenue $274 million to $280 million.Q3 revenue $66.7 million versus I/B/E/S view $65.4 million.FY 2017 earnings per share view $0.06, revenue view $277.8 million -- Thomson Reuters I/B/E/S.  Full Article

RTI Surgical names Robert Jordheim as interim CEO
Wednesday, 14 Dec 2016 

RTI Surgical Inc - : RTI board of directors continues to actively review candidates for permanent chief executive officer position . Jordheim's CFO responsibilities will be assumed on an interim basis by Wy Louw, vice president and controller of RTI . Transition of Jordheim will be completed December 17, 2016 . Jordheim succeeds Brian K. Hutchison .RTI Surgical names Robert P. Jordheim interim CEO.  Full Article

RTI Surgical announces CEO Brian Hutchison to retire
Monday, 15 Aug 2016 

Rti Surgical Inc : RTI surgical announces CEO Brian Hutchison to retire .RTI's board is commencing a search for chief executive officer position.  Full Article

RTI Surgical reports Q2 loss per share $0.05
Wednesday, 27 Jul 2016 

Rti Surgical Inc : RTI Surgical announces 2016 second quarter results . RTI surgical Inc says management and board of directors are launching a comprehensive strategic review of company's business lines . FY2016 earnings per share view $0.19, revenue view $284.1 million -- Thomson Reuters I/B/E/S . Q2 revenue $67.6 million versus i/b/e/s view $66.5 million . Sees FY 2016 adjusted earnings per share $0.09 to $0.12 excluding items . Sees FY 2016 earnings per share $0.03 to $0.06 . Sees FY 2016 revenue $274 million to $280 million . Sees q2 2016 earnings per share $0.09 to $0.12 excluding items . Q2 earnings per share view $0.03 -- Thomson Reuters I/B/E/S . RTI surgical inc says achieved q2 worldwide direct revenues of $39.6 million, a 16 percent increase over q2 of 2015 .RTI Surgical Inc says intends to engage a management consulting firm to assist with strategic review.  Full Article

RTI Surgical entered into fourth amendment to second amended and restated loan agreement
Tuesday, 5 Jul 2016 

RTI Surgical Inc : Says entered into a fourth amendment to second amended and restated loan agreement, dated as of July 16, 2013 - Sec Filing .Parties to loan agreement entered into amendment in order to increase maximum revolving credit amount from $30 million to $45 million.  Full Article

BRIEF-RTI Surgical Outlines 2018 Guidance And Long-Term Goals

* RTI SURGICAL INC - EXPECTS FULL YEAR REVENUES IN RANGE OF $280 MILLION AND $290 MILLION